BRPI0821455A2 - Amlopidine and valsartan pharmaceutical compositions - Google Patents

Amlopidine and valsartan pharmaceutical compositions

Info

Publication number: BRPI0821455A2
Authority: BR; Brazil
Prior art keywords: amlopidine; pharmaceutical compositions; valsartan pharmaceutical; valsartan; compositions
Prior art date: 2007-12-31

Application number

BRPI0821455-7A

Other languages

Portuguese (pt)

Inventor

Anirudha Bhagirath Kute E Outros

Nikhil Prabhakar Malewar

Makarand Krishnajkumar Avachat

Original Assignee

Lupin Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2007-12-31

Filing date

2008-02-21

Publication date

2015-06-16

2008-02-21 Application filed by Lupin Ltd filed Critical Lupin Ltd

2015-06-16 Publication of BRPI0821455A2 publication Critical patent/BRPI0821455A2/en

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4422—1,4-Dihydropyridines, e.g. nifedipine, nicardipine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives

Landscapes

Health & Medical Sciences (AREA)
Public Health (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
Veterinary Medicine (AREA)
Chemical & Material Sciences (AREA)
General Health & Medical Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Medicinal Chemistry (AREA)
Epidemiology (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Heart & Thoracic Surgery (AREA)
Cardiology (AREA)
Urology & Nephrology (AREA)
Vascular Medicine (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicinal Preparation (AREA)

BRPI0821455-7A 2007-12-31 2008-02-21 Amlopidine and valsartan pharmaceutical compositions BRPI0821455A2 (en)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
IN1449KO2007		2007-12-31
PCT/IN2008/000103 WO2009084003A1 (en)	2007-12-31	2008-02-21	Pharmaceutical compositions of amlodipine and valsartan

Publications (1)

Publication Number	Publication Date
BRPI0821455A2 true BRPI0821455A2 (en)	2015-06-16

Family

ID=39739299

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
BRPI0821455-7A BRPI0821455A2 (en)	2007-12-31	2008-02-21	Amlopidine and valsartan pharmaceutical compositions

Country Status (8)

Country	Link
US (1)	US8785432B2 (en)
EP (1)	EP2240163A1 (en)
JP (1)	JP2011507973A (en)
AU (1)	AU2008344891A1 (en)
BR (1)	BRPI0821455A2 (en)
MX (1)	MX2010007281A (en)
WO (1)	WO2009084003A1 (en)
ZA (1)	ZA201005442B (en)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JP6041591B2 (en) *	2011-09-13	2016-12-14	大日本住友製薬株式会社	Stabilized pharmaceutical composition comprising irbesartan and amlodipine or a salt thereof
JP6081376B2 (en) *	2011-12-28	2017-02-15	ニプロ株式会社	Solid pharmaceutical composition containing a compound having angiotensin II antagonistic activity
WO2014038895A1 (en) *	2012-09-06	2014-03-13	한국콜마주식회사	Solid oral dosage form containing valsartan, and preparation method therefor
CZ2013783A3 (en)	2013-10-08	2015-04-15	Zentiva, K. S	Stable pharmaceutical composition containing amlodipine and valsartan
EP3320903B1 (en) *	2015-07-08	2021-05-19	HK inno.N Corporation	Pharmaceutical composition containing amlodipine, valsartan, and rosuvastatin
WO2019135691A1 (en) *	2018-01-04	2019-07-11	Jamjoom Pharmaceuticals Factory Company Limited	A stable mono-layer solid dosage form containing combination of two active ingredients
CN109010338B (en) *	2018-09-13	2021-09-21	合肥合源药业有限公司	Preparation method of valsartan amlodipine tablets and valsartan amlodipine tablets
CN109394712B (en) *	2018-11-23	2019-11-12	海南妙音春制药有限公司	A kind of valsartan amlodipine composite tablet and preparation method thereof
CN112641743B (en) *	2020-12-23	2022-09-02	上海耀大生物科技有限公司	Compound preparation for treating hypertension and preparation process thereof

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DK161312C (en)	1982-03-11	1991-12-09	Pfizer	CHANGES FOR THE PREPARATION FOR THE PREPARATION OF 2-Amino-CO-Methyl-4-Methyl-4-Methyl-4-Methyl-4-Methyl-4-Methyl-4-Methyl-2-D-Hydroxy
GB8608335D0 (en)	1986-04-04	1986-05-08	Pfizer Ltd	Pharmaceutically acceptable salts
US4879903A (en) *	1988-09-02	1989-11-14	Nova Sensor	Three part low cost sensor housing
DE59107440D1 (en)	1990-02-19	1996-04-04	Ciba Geigy Ag	Acyl compounds
GB9613470D0 (en)	1996-06-27	1996-08-28	Ciba Geigy Ag	Small solid oral dosage form
WO2000002543A2 (en) *	1998-07-10	2000-01-20	Novartis Ag	Antihypersensitive combination of valsartan and calcium channel blocker
US6395728B2 (en)	1999-07-08	2002-05-28	Novartis Ag	Method of treatment and pharmaceutical composition
EG24716A (en) *	2002-05-17	2010-06-07	Novartis Ag	Combination of organic compounds
GT200600371A (en) *	2005-08-17	2007-03-21		SOLID DOSE FORMS OF VALSARTAN AND AMLODIPINE AND METHOD TO DO THE SAME
GB0601405D0 (en) *	2006-01-24	2006-03-08	Novartis Ag	Organic Compounds

2008
- 2008-02-21 BR BRPI0821455-7A patent/BRPI0821455A2/en not_active IP Right Cessation
- 2008-02-21 EP EP08738366A patent/EP2240163A1/en not_active Withdrawn
- 2008-02-21 JP JP2010541141A patent/JP2011507973A/en active Pending
- 2008-02-21 AU AU2008344891A patent/AU2008344891A1/en not_active Abandoned
- 2008-02-21 US US12/810,662 patent/US8785432B2/en not_active Expired - Fee Related
- 2008-02-21 WO PCT/IN2008/000103 patent/WO2009084003A1/en active Application Filing
- 2008-02-21 MX MX2010007281A patent/MX2010007281A/en not_active Application Discontinuation
2010
- 2010-07-29 ZA ZA2010/05442A patent/ZA201005442B/en unknown

Also Published As

Publication number	Publication date
ZA201005442B (en)	2011-04-28
US20100272801A1 (en)	2010-10-28
US8785432B2 (en)	2014-07-22
EP2240163A1 (en)	2010-10-20
WO2009084003A1 (en)	2009-07-09
MX2010007281A (en)	2010-10-05
AU2008344891A1 (en)	2009-07-09
JP2011507973A (en)	2011-03-10

Publication	Publication Date	Title
LTPA2018014I1 (en)	2018-12-10	Pharmaceutical Composition 514
LTPA2018005I1 (en)	2018-02-12	Pharmaceutical composition
IL242883B (en)	2022-01-01	Arylamino- and heteroarylamino-substituted dioxoazolines and pharmaceutical compositions comprising them
BRPI0715712A2 (en)	2014-06-24	PHARMACEUTICAL COMPOSITION
DK3492069T3 (en)	2022-03-14	PHARMACEUTICAL COMPOSITIONS INCLUDING IRON-OXY-HYDROXIDE
BRPI0721651A2 (en)	2014-04-01	PHARMACEUTICAL COMPOSITION
BRPI0719393A2 (en)	2015-03-31	Pharmaceutical Composition
BRPI0905715A2 (en)	2015-07-14	Pharmaceutical Composition and Component Kit
BRPI0716445A2 (en)	2013-09-17	pharmaceutical composition
BRPI0720234A2 (en)	2013-12-24	PHARMACEUTICAL COMPOSITION
EP2154966A4 (en)	2010-12-15	BENZIMIDAZOLES AND PHARMACEUTICAL COMPOSITIONS THEREOF
BRPI0908132A2 (en)	2015-08-04	Benzodiazepine Compound and Pharmaceutical Composition
DK2120884T3 (en)	2011-02-07	Pharmaceutical composition
IL206594A (en)	2015-05-31	Azinone-tetrahydropyridoindole derivatives and pharmaceutical compositions comprising thereof
IL200885A (en)	2014-01-30	Substituted mannich-based compounds and pharmaceutical compositions comprising such
BRPI0821455A2 (en)	2015-06-16	Amlopidine and valsartan pharmaceutical compositions
BRPI0817833A2 (en)	2015-03-31	Antimalarial Pharmaceutical Composition
BRPI0820198A2 (en)	2019-09-24	pharmaceutical compositions
IL201894A (en)	2013-07-31	Quinolone compound and pharmaceutical composition comprising it
BRPI0807903A2 (en)	2014-06-17	IMPROVED MEDICAL COMPOSITIONS UNDERSTANDING BUPRENORPHINE AND NALMEPHEN.
DK2271321T3 (en)	2012-08-27	Pharmaceutical Composition 271
GB0614365D0 (en)	2006-08-30	Pharmaceutical compositions and their use
BRPI0912074A2 (en)	2018-10-02	compound and pharmaceutical composition
DK2231603T3 (en)	2013-06-03	Substituted 3-hydroxypyridines and pharmaceutical compositions thereof
BRPI0820839A2 (en)	2015-06-16	Pharmaceutical Composition

Legal Events

Date	Code	Title	Description
2015-12-01	B08F	Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]	Free format text: REFERENTE AS 6A E 7A ANUIDADES.
2016-04-05	B08K	Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]	Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2343 DE 01-12-2015 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.